最近搜索:細(xì)胞培養(yǎng) 微生物學(xué) 分子生物 生物化學(xué)
    首頁(yè)>>免疫學(xué)>>一抗>>骨保護(hù)蛋白配體/破骨細(xì)胞分化因子抗體
    骨保護(hù)蛋白配體/破骨細(xì)胞分化因子抗體
    • 產(chǎn)品貨號(hào):
      BN40621R
    • 中文名稱:
      骨保護(hù)蛋白配體/破骨細(xì)胞分化因子抗體
    • 英文名稱:
      Rabbit anti-RANKL/CD254 Polyclonal antibody
    • 品牌:
      Biorigin
    • 貨號(hào)

      產(chǎn)品規(guī)格

      售價(jià)

      備注

    • BN40621R-100ul

      100ul

      ¥2360.00

      交叉反應(yīng):Human,Mouse,Rat(predicted:Dog,Horse,Rabbit) 推薦應(yīng)用:WB,Flow-Cyt

    • BN40621R-200ul

      200ul

      ¥3490.00

      交叉反應(yīng):Human,Mouse,Rat(predicted:Dog,Horse,Rabbit) 推薦應(yīng)用:WB,Flow-Cyt

    產(chǎn)品描述

    英文名稱RANKL/CD254
    中文名稱骨保護(hù)蛋白配體/破骨細(xì)胞分化因子抗體
    別    名OPGL; CD254; hRANKL2; ODF; OPGL; Osteoclast differentiation factor; Osteoprotegerin ligand; RANKL; Receptor activator of nuclear factor kappa B ligand; sOdf; SOFA; TNF related activation induced cytokine; TNFSF 11; TNFSF11; TRANCE; Tumor necrosis factor ligand superfamily member 11; Osteoprotegerin Ligand; TNF11_HUMAN.  
    研究領(lǐng)域腫瘤  細(xì)胞生物  免疫學(xué)  發(fā)育生物學(xué)  
    抗體來(lái)源Rabbit
    克隆類型Polyclonal
    交叉反應(yīng)Human, Mouse, Rat,  (predicted: Dog, Horse, Rabbit, )
    產(chǎn)品應(yīng)用WB=1:500-2000 Flow-Cyt=1ug/Test 
    not yet tested in other applications.
    optimal dilutions/concentrations should be determined by the end user.
    分 子 量35kDa
    細(xì)胞定位細(xì)胞漿 細(xì)胞膜 分泌型蛋白 
    性    狀Liquid
    濃    度1mg/ml
    免 疫 原KLH conjugated synthetic peptide derived from human RANKL/CD254:131-230/317 
    亞    型IgG
    純化方法affinity purified by Protein A
    儲(chǔ) 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
    保存條件Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
    PubMedPubMed
    產(chǎn)品介紹This gene encodes a member of the tumor necrosis factor (TNF) cytokine family which is a ligand for osteoprotegerin and functions as a key factor for osteoclast differentiation and activation. This protein was shown to be a dentritic cell survival factor and is involved in the regulation of T cell-dependent immune response. T cell activation was reported to induce expression of this gene and lead to an increase of osteoclastogenesis and bone loss. This protein was shown to activate antiapoptotic kinase AKT/PKB through a signaling complex involving SRC kinase and tumor necrosis factor receptor-associated factor (TRAF) 6, which indicated this protein may have a role in the regulation of cell apoptosis. Targeted disruption of the related gene in mice led to severe osteopetrosis and a lack of osteoclasts. The deficient mice exhibited defects in early differentiation of T and B lymphocytes, and failed to form lobulo-alveolar mammary structures during pregnancy. Two alternatively spliced transcript variants have been found. [provided by RefSeq, Jul 2008].

    Function:
    Cytokine that binds to TNFRSF11B/OPG and to TNFRSF11A/RANK. Osteoclast differentiation and activation factor. Augments the ability of dendritic cells to stimulate naive T-cell proliferation. May be an important regulator of interactions between T-cells and dendritic cells and may play a role in the regulation of the T-cell-dependent immune response. May also play an important role in enhanced bone-resorption in humoral hypercalcemia of malignancy.

    Subcellular Location:
    Cytoplasm; Secreted and Cell membrane.

    Tissue Specificity:
    Highest in the peripheral lymph nodes, weak in spleen, peripheral blood Leukocytes, bone marrow, heart, placenta, skeletal muscle, stomach and thyroid.

    Post-translational modifications:
    The soluble form of isoform 1 derives from the membrane form by proteolytic processing. The cleavage may be catalyzed by ADAM17.

    DISEASE:
    Defects in TNFSF11 are the cause of osteopetrosis autosomal recessive type 2 (OPTB2) [MIM:259710]; also known as osteoclast-poor osteopetrosis. Osteopetrosis is a rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. The disorder occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Autosomal recessive osteopetrosis is usually associated with normal or elevated amount of non-functional osteoclasts. OPTB2 is characterized by paucity of osteoclasts, suggesting a molecular defect in osteoclast development.

    Similarity:
    Belongs to the tumor necrosis factor family.

    SWISS:
    O14788

    Gene ID:
    8600

    Database links:

    Entrez Gene: 8600 Human

    Entrez Gene: 21943 Mouse

    Omim: 602642 Human

    SwissProt: O14788 Human

    SwissProt: O35235 Mouse

    Unigene: 333791 Human

    Unigene: 249221 Mouse



    Important Note:
    This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

    OPGL骨保護(hù)蛋白配體又稱骨保護(hù)素配體(破骨細(xì)胞發(fā)育刺激因子)。屬腫瘤壞死因子TNF-a家族。
    OPGL促進(jìn)破骨細(xì)胞的分化和活性,而OPG抑制這些過(guò)程。骨髓瘤細(xì)胞影響骨髓中這兩種蛋白的生理平衡,是發(fā)生溶骨性病變的根本所在。


    久久久久亚洲av无码专区蜜芽| 精品久久久久久亚洲精品| 亚洲一区二区三区久久| 亚洲va无码专区国产乱码| 亚洲视频人成在线播放| 老司机亚洲精品影院在线观看| 亚洲自国产拍揄拍| 亚洲婷婷第一狠人综合精品| 亚洲一区二区久久| 亚洲国产日韩综合久久精品| 精品亚洲AV无码一区二区三区| 亚洲一区二区三区深夜天堂| 亚洲乱码中文字幕小综合| 亚洲AV无码成人专区| 亚洲男人的天堂久久精品| 亚洲日韩国产精品乱-久| 亚洲真人无码永久在线观看| 亚洲性色精品一区二区在线| 亚洲熟妇AV日韩熟妇在线| 亚洲精品国产综合久久久久紧| 亚洲色大成网站www永久网站| 成人亚洲国产va天堂| 亚洲精品成a人在线观看☆| 久久久久亚洲AV无码去区首| 国产成人精品久久亚洲高清不卡| 色偷偷亚洲男人天堂| 亚洲女同成人AⅤ人片在线观看| 亚洲熟妇少妇任你躁在线观看无码 | 中文字幕第一页亚洲| 亚洲人成网站在线观看播放| 亚洲国产综合无码一区| 亚洲av无码专区在线播放| 亚洲午夜久久久精品影院| 亚洲欧洲日韩国产| 伊人久久五月丁香综合中文亚洲| 亚洲heyzo专区无码综合| 亚洲毛片av日韩av无码| 久久亚洲高清观看| 亚洲视频国产精品| 亚洲AV成人噜噜无码网站| 亚洲人成色4444在线观看|